$MGHL
MORGAN GROUP HOLDING CO

2019 Q3 Form 10-Q Financial Statement

#000114036119014697 Filed on August 09, 2019

View on sec.gov

Income Statement

Concept 2019 Q3 2019 Q2 2018 Q2
Revenue $2.396M $2.155M $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $32.81K $11.65K $10.00K
YoY Change 228.1% 16.5% 0.0%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $2.813M $3.234M $10.00K
YoY Change 28028.21% 32235.32% 0.0%
Operating Profit
YoY Change
Interest Expense $460.00 $580.00 $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$416.8K -$1.079M -$11.12K
YoY Change 4549.21% 9598.1% 11.23%
Income Tax -$83.78K -$245.6K $0.00
% Of Pretax Income
Net Earnings -$333.0K -$833.2K -$11.12K
YoY Change 3614.68% 7390.44% 11.23%
Net Earnings / Revenue -13.9% -38.67%
Basic Earnings Per Share
Diluted Earnings Per Share -$665.8K -$228.0K -$2.058K
COMMON SHARES
Basic Shares Outstanding 4.859M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q3 2019 Q2 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $79.07K $91.27K $140.0K
YoY Change -39.18% -34.81% 366.67%
Cash & Equivalents $5.504M $5.651M $142.7K
Short-Term Investments
Other Short-Term Assets $9.880K $11.83K $20.00K
YoY Change -1.2% -40.85% 100.0%
Inventory
Prepaid Expenses $9.875K $11.83K $17.77K
Receivables
Other Receivables
Total Short-Term Assets $88.95K $103.1K $160.5K
YoY Change -38.98% -35.74% 434.86%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $88.95K $103.1K $160.5K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $88.95K $103.1K $160.5K
YoY Change -38.98% -35.74% 434.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $18.19K $0.00 $5.949K
YoY Change 8095.05% -100.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $18.19K $0.00 $5.949K
YoY Change 8095.05% -100.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $18.19K $0.00 $5.949K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $18.19K $0.00 $5.949K
YoY Change 8095.05% -100.0%
SHAREHOLDERS EQUITY
Retained Earnings -$5.915M -$5.883M -$5.831M
YoY Change 1.28% 0.88%
Common Stock $48.59K $48.59K $48.59K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.811M $5.144M $154.5K
YoY Change
Total Liabilities & Shareholders Equity $88.95K $103.1K $160.5K
YoY Change -38.98% -35.74% 434.86%

Cashflow Statement

Concept 2019 Q3 2019 Q2 2018 Q2
OPERATING ACTIVITIES
Net Income -$333.0K -$833.2K -$11.12K
YoY Change 3614.68% 7390.44% 11.23%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$12.19K -$23.04K -$50.00K
YoY Change 21.9% -53.92% 400.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 180.0K
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -12.19K -23.04K -50.00K
Cash From Investing Activities 0.000
Cash From Financing Activities 0.000 0.000 180.0K
Net Change In Cash -12.19K -23.04K 130.0K
YoY Change 21.9% -117.72% -1400.0%
FREE CASH FLOW
Cash From Operating Activities -$12.19K -$23.04K -$50.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Shell Company
EntityShellCompany
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Small Business
EntitySmallBusiness
true
CY2018Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5949
CY2019Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
0
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
MORGAN GROUP HOLDING CO
dei Entity Central Index Key
EntityCentralIndexKey
0001162283
CY2019Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4859055
dei Amendment Flag
AmendmentFlag
false
dei Entity Address Country
EntityAddressCountry
US
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Period End Date
DocumentPeriodEndDate
2019-06-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
222
CY2018Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5937368
CY2019Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5937368
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5937368
CY2019Q2 us-gaap Assets
Assets
103104
CY2018Q4 us-gaap Assets
Assets
137089
CY2018Q2 us-gaap Assets
Assets
160457
CY2018Q2 us-gaap Assets Current
AssetsCurrent
160457
CY2018Q4 us-gaap Assets Current
AssetsCurrent
137089
CY2019Q2 us-gaap Assets Current
AssetsCurrent
103104
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-38365
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
125411
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17273
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
129635
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
142684
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
91270
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
129635
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
91270
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
142684
us-gaap Net Income Loss
NetIncomeLoss
-33763
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4859055
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4859055
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4859055
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
48591
CY2018Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
48591
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
48591
us-gaap Debt Securities Trading Unrealized Loss
DebtSecuritiesTradingUnrealizedLoss
0
CY2018 us-gaap Debt Securities Trading Unrealized Loss
DebtSecuritiesTradingUnrealizedLoss
0
us-gaap Debt Securities Trading Unrealized Loss
DebtSecuritiesTradingUnrealizedLoss
0
us-gaap Debt Securities Trading Unrealized Gain
DebtSecuritiesTradingUnrealizedGain
0
us-gaap Debt Securities Trading Unrealized Gain
DebtSecuritiesTradingUnrealizedGain
0
CY2018 us-gaap Debt Securities Trading Unrealized Gain
DebtSecuritiesTradingUnrealizedGain
0
CY2019Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
201972
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-11123
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-11079
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-33763
CY2018Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5949
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11744
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11654
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
38765
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
35010
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-38099
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-222
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
955
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
4380
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
17445
us-gaap Interest Paid Net
InterestPaidNet
0
us-gaap Interest Paid Net
InterestPaidNet
0
CY2018Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
621
CY2019Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
575
us-gaap Investment Income Interest
InvestmentIncomeInterest
666
us-gaap Investment Income Interest
InvestmentIncomeInterest
1247
CY2019Q2 us-gaap Liabilities
Liabilities
0
CY2018Q4 us-gaap Liabilities
Liabilities
222
CY2018Q2 us-gaap Liabilities
Liabilities
5949
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
103104
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
160457
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
137089
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
222
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
0
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-38365
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-54589
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
180000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-11079
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-11123
us-gaap Net Income Loss
NetIncomeLoss
-38099
us-gaap Payments To Suppliers
PaymentsToSuppliers
55255
us-gaap Payments To Suppliers
PaymentsToSuppliers
39612
CY2018Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2019Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2019Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2018Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2019Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
11834
CY2018Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7454
CY2018Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
17773
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
180000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
us-gaap Proceeds From Interest And Dividends Received
ProceedsFromInterestAndDividendsReceived
666
us-gaap Proceeds From Interest And Dividends Received
ProceedsFromInterestAndDividendsReceived
1247
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5882855
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5849092
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5831451
CY2018Q2 us-gaap Revenues
Revenues
0
us-gaap Revenues
Revenues
0
CY2019Q2 us-gaap Revenues
Revenues
0
us-gaap Revenues
Revenues
0
CY2002Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
2820051
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
154508
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
103104
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
136867
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4859055
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4859055
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4212464
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4859055
CY2002Q1 mghl Shares Retained During Period
SharesRetainedDuringPeriod
235294

Files In Submission

Name View Source Status
0001140361-19-014697-index-headers.html Edgar Link pending
0001140361-19-014697-index.html Edgar Link pending
0001140361-19-014697.txt Edgar Link pending
0001140361-19-014697-xbrl.zip Edgar Link pending
ex31_1.htm Edgar Link pending
ex32_1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10q.htm Edgar Link pending
mghl-20190630.xml Edgar Link completed
mghl-20190630.xsd Edgar Link pending
mghl-20190630_cal.xml Edgar Link unprocessable
mghl-20190630_def.xml Edgar Link unprocessable
mghl-20190630_lab.xml Edgar Link unprocessable
mghl-20190630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending